Company Filing History:
2 out of 812 
2 out of 1,168 Years Active: 2016-2020
Title: Michal Dadon-Nachum: Innovator in Muscle Cell Research
Introduction
Michal Dadon-Nachum is a prominent inventor based in Kfar-Saba, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of genetically modified muscle cells. With a total of 2 patents, his work focuses on advancing our understanding of muscle progenitor cells and their potential applications.
Latest Patents
Dadon-Nachum's latest patents include groundbreaking research on genetically modified muscle cells that express neurotrophic factors. One of his notable inventions involves an isolated muscle progenitor cell that is MyoD positive, CD34 negative, and CD45 negative. This muscle progenitor cell is genetically modified to express at least one neurotrophic factor. Furthermore, he has disclosed cell populations that comprise at least four subpopulations of muscle cells, each genetically modified to express a different neurotrophic factor. These neurotrophic factors include glial derived neurotrophic factor (GDNF), insulin growth factor (IGF-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF). The potential uses of these cell populations are also outlined in his patents.
Career Highlights
Throughout his career, Michal Dadon-Nachum has worked with esteemed organizations such as Ramot at Tel Aviv University Ltd. and Yeda Research and Development Company Ltd. His innovative research has positioned him as a key figure in the biotechnology sector, contributing to advancements in muscle cell applications.
Collaborations
Dadon-Nachum has collaborated with notable colleagues, including Daniel Offen and Tali Ben-Zur. These partnerships have further enriched his research and development efforts in the field.
Conclusion
In summary, Michal Dadon-Nachum is a distinguished inventor whose work in genetically modified muscle cells has the potential to impact various therapeutic applications. His contributions to biotechnology continue to pave the way for future innovations in the field.